From November 2009 until December 2010, 91 patients with 100 articular joints were treated with autologous ADSCs in the form of stromal vascular fraction (SVF) along with autologous PRP.

Objective: To appraise existing evidence for prolotherapy, polidocanol, autologous whole blood and platelet-rich plasma injection therapies for lateral epicondylosis (LE). Design: Systematic review.

Robotic joint reconstruction offers patients faster recovery, less pain, and personalized outcomes—here’s how it’s reshaping ...

Dr. MedLaw explains the importance of discussing risks, benefits, and alternatives in a manner the patient fully understands ...

The knee hyaluronic acid injections market is expected to grow from USD 2.28 billion in 2025 to USD 3.97 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% during the forecast ...

The newly formed joint venture combines Centex’s agility, innovation, and socio-economic status with Sterling’s deep federal expertise, contract performance history, and industry buying power.

Achieving informed consent requires a potential contributor to be in possession of sufficient knowledge about our plans for a reasoned decision to take part in our content. The Editorial ...

Incannex's reports filed with the U.S. Securities and Exchange Commission (SEC) including its annual report on Form 10-K for the fiscal year ended June 30, 2024, filed with the SEC on September 30 ...

Platelet-rich plasma injections for the treatment of chronic Achilles tendinopathy has become increasingly popular among sports medicine physicians as an alternative to surgery.

Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne June 17, 2025 — 07:41 am EDT Written by None for Quiver Quantitative -> ...

Platelet-rich plasma (PRP) is a commonly used treatment for tendinopathies such as tennis elbow despite the questionable evidence of its efficacy. A recent Cochrane review suggests that it likely does ...

Odyssey Marine Exploration Inc. (NASDAQ: OMEX), a pioneer in deep-ocean exploration whose stock has surged over 180% in the past six months according to InvestingPro data, has entered into a joint ...